You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Esophageal Squamous Cell Carcinoma (ESSC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
  • Qingdao, Shandong, China
  • +1 more
Nov 13, 2023

Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • no intervention
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jul 29, 2023

Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shijiazhuang, Hebei, China
      Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
    Oct 25, 2023

    Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Head and Neck Squamous Cell Carcinoma
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Oct 25, 2023

    Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Nov 30, 2023

    Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
    • (no location specified)
    Mar 17, 2023

    Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

    Not yet recruiting
    • Advanced Esophageal Squamous Carcinoma With Oligometastases
    • simultaneous with radiotherapy
    • synchronous with radiotherapy
    • (no location specified)
    Nov 16, 2023

    The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

    Recruiting
    • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
    • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
    • Hanzhou, Zhejiang, China
      Lulu Liu
    Jul 14, 2023

    Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
    • (no location specified)
    Aug 17, 2023

    Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

    Not yet recruiting
    • Minimal Residual Disease
    • Esophageal Squamous Cell Carcinoma
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Jun 10, 2023

      Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

      Not yet recruiting
      • Esophageal Cancer
      • +2 more
      • (no location specified)
      Aug 21, 2023

      Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma
      • (no location specified)
      Aug 28, 2023

      Esophageal Cancer Trial in Wuhan

      Recruiting
      • Esophageal Cancer
        • Wuhan, Hubei, China
          Renmin hosptial of Wuhan University
        Jun 7, 2023

        Esophageal Squamous Cell Carcinoma Trial in Wuhan (Intensity-modulated radiotherapy (IMRT), Tislelizumab, Cisplatin)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • Intensity-modulated radiotherapy (IMRT)
        • +3 more
        • Wuhan, Hubei, China
          Renmin hosptial of Wuhan University
        Jun 16, 2023

        Resectable Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial (cadonilimab+chemo)

        Not yet recruiting
        • Resectable Esophageal Squamous Cell Carcinoma
        • Neoadjuvant Therapy
        • (no location specified)
        Apr 18, 2023

        ctDNA-MRD in Predicting Efficacy of Esophageal Squamous Cell

        Not yet recruiting
        • Squamous Cell Carcinoma of Esophagus
          • (no location specified)
          Feb 25, 2023

          Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to

          Active, not recruiting
          • Esophageal Cancer
          • follow up
          • Guangzhou, Guangdong, China
            Jianhua Fu
          Sep 24, 2023

          Esophageal Squamous Cell Carcinoma Trial in Hangzhou (Cadonilimab combined Anlotinib)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • Cadonilimab combined Anlotinib
          • Hangzhou, Zhejiang, China
            2nd Affiliated Hospital, School of Medicine, Zhejiang University
          Aug 6, 2023

          Esophageal Squamous Cell Carcinoma Trial (XH-30002 capsule, Afatiinb tablet)

          Not yet recruiting
          • Esophageal Squamous Cell Carcinoma
          • XH-30002 capsule
          • Afatiinb tablet
          • (no location specified)
          Jun 25, 2023

          Esophageal Squamous Cell Carcinoma Trial in Shanghai (Tirelizumab, Nab paclitaxel, Carboplatin)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • Shanghai, Shanghai, China
            Ruijin hospital, Shanghai jiaotong university school of medicine
          Nov 6, 2023

          Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • +2 more
          • LDRT+CFRT
          • +2 more
          • Shanghai, China
          • +1 more
          Aug 3, 2023

          Esophageal Squamous Cell Carcinoma Trial in Shantou (Tislelizumab)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • Shantou, Guangdong, China
            Cancer Hospital of Shantou University Medical College
          Aug 2, 2023

          Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)

          Not yet recruiting
          • Esophageal Carcinoma
          • Immune Checkpoint Inhibitors
          • (no location specified)
          Jul 6, 2023

          Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • +2 more
          • Shanghai, Shanghai, China
            Shanghai chest hospital
          Sep 24, 2023

          Esophageal Squamous Cell Carcinoma (ESCC), PD-1 Inhibitors Trial in Zhengzhou (IBI110+Sintilimab)

          Not yet recruiting
          • Esophageal Squamous Cell Carcinoma (ESCC)
          • PD-1 Inhibitors
          • Zhengzhou, Henan, China
            Feng Wang
          Oct 9, 2023